Get started
Author

Jeffrey Seow

Observed names: J Seow, J. Seow, JEFFREY TIEN-JIE SEOW, jeffrey seow
ORCID: 0000-0003-0722-8561
Observed ORCID: 0000-0003-0722-8561
OpenAlex ID: A5034026446
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
2020 · Jeffrey Seow, Carl Graham, et al. · Nature Microbiology · 1,422
PDF
A dynamic COVID-19 immune signature includes associations with poor prognosis
2020 · Adam G. Laing, Anna Lorenc, et al. · Nature Medicine · 943
PDF
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
2021 · Leticia Monin, Adam G Laing, et al. · The Lancet Oncology · 612
PDF
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection
2020 · Michael J. Carter, Matthew Fish, et al. · Nature Medicine · 419
PDF
The effect of spike mutations on SARS-CoV-2 neutralization
2021 · Chloe Rees-Spear, Luke Muir, et al. · Cell Reports · 215
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
2021 · Annachiara Rosa, Valerie E. Pye, et al. · Science Advances · 152
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
2021 · Carl Graham, Jeffrey Seow, et al. · Immunity · 152
PDF
The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate
2021 · Sarah Gee, Manju Chandiramani, et al. · Nature Immunology · 111
PDF
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
2020 · Suzanne Pickering, Gilberto Betancor, et al. · PLoS Pathogens · 107
PDF
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
2021 · Liane Dupont, Luke B. Snell, et al. · Nature Microbiology · 105
PDF
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
2022 · CA Fielding, P Sabberwal, et al. · eLife · 88
A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex
2019 · Victoria A. Avanzato, Kasopefoluwa Y. Oguntuyo, et al. · Proceedings of the National Academy of Sciences · 74
PDF
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
2020 · Adam G. Laing, Anna Lorenc, et al. · Nature Medicine · 68
PDF
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England
2020 · Philippa M. Wells, Katie J. Doores, et al. · Journal of Infection · 63
PDF
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia
2021 · Patrick Harrington, Katie J. Doores, et al. · British Journal of Haematology · 62
PDF
ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition—implications for COVID-19
2022 · Julia S. El-Sayed Moustafa, Anne U. Jackson, et al. · International Journal of Obesity · 48
PDF
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination
2022 · Jeffrey Seow, Hataf Khan, et al. · Cell Reports · 46
PDF
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
2021 · Patrick Harrington, Hugues de Lavallade, et al. · Leukemia · 45
PDF
The impact of Spike mutations on SARS-CoV-2 neutralization
2021 · C Rees-Spear, L Muir, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 45
PDF
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies
2023 · Nathan J. Cheetham, Milla Kibble, et al. · eLife · 39
Disordered epitopes as peptide vaccines
2018 · Christopher A. MacRaild, Jeffrey Seow, et al. · Peptide Science · 38
PDF
Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer
2021 · Duncan R. McKenzie, Miguel Muñoz-Ruiz, et al. · Cancer Cell · 35
PDF
Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals
2022 · Thomas Lechmere, Luke B. Snell, et al. · mBio · 33
Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate
2015 · Rodrigo A. V. Morales, Christopher A. MacRaild, et al. · Scientific Reports · 31
PDF
Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein
2020 · Ilona Rissanen, Robert Stass, et al. · eLife · 28
Works count: 60
Citation count: 5,217
H-index: 26
I10-index: 35
Year
Topic
Type